TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Inspira Technologies Oxy BHN ( (IINN) ) is now available.
On September 18, 2025, Inspira Technologies announced the unveiling of its HYLA Real-Time Blood Sensor at the U.S. ELSO Annual Conference, scheduled for September 27-30, 2025. The HYLA sensor, which boasts a 97.35% accuracy rate, will be presented to the global medical community, marking a shift from internal validation to engaging with key opinion leaders and potential commercial partners. This event is expected to enhance Inspira’s industry positioning and foster strategic partnerships. Additionally, Inspira will showcase its FDA-cleared ART100 system, further emphasizing its comprehensive platform of advanced life-support and monitoring solutions.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the FDA-cleared INSPIRA ART100 system for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. They are also developing the INSPIRA ART500, a next-generation system for oxygenation while patients remain awake. Additionally, Inspira is advancing the HYLA blood sensor platform for continuous, non-invasive monitoring, positioning itself as a significant player in the life-support and MedTech landscape.
Average Trading Volume: 1,150,663
Technical Sentiment Signal: Buy
Current Market Cap: $29.97M
Learn more about IINN stock on TipRanks’ Stock Analysis page.